FDA Lightens Up on Pre-Market and Post-Market Software Regulation

Event Information
Product Format
Prerecorded Event
Conference Date
Tue, Mar 27, 2018
60 minutes
Product Description

Learn the FDA’s Options to Reduce Your Pre- and Post-Market Software Compliance Requirements

The FDA provides options to reduce your pre-market and post-market requirements for software and, therefore, the related cost of compliance. The FDA recognizes that the industry, and not the FDA, holds the technical knowledge required to manage or develop software developments. The FDA also acknowledges that it cannot keep pace with cybersecurity problems – it has tried, but performed poorly, to keep up with the software issues and resilience. Even the FBI has expressed this concern.

Congress has enacted a new legislation to remove low-risk software from the FDA’s jurisdiction. You now have the option of working with other manufacturers to address cybersecurity issues and avoid the need to report your corrective action under the Corrections and Removals regulation (21 CFR Part 806). How that changes FDA’s programs and guidance on software will remain in flux for a few years. As a result, you need to work on developing your organizational plans separate from what the FDA provides.

Join regulatory guidance expert Casper E. Uldriks to discuss the FDA’s options to reduce your pre- and post-market requirements for software. Through the use of an abbreviated 510(k) paradigm, manufacturers have new ways to expedite their market access with new software. The use of voluntary standards lightens the work load on developing and submitting a 510(k) for review. The informational content of the pre-market submission should now be much easier for most software 510(k) submissions. This session will focus on software 510(k) submissions.

On the post-market side of the FDA’s relief options, manufacturers can voluntarily participate in an Information Sharing Analysis Organization (ISAO) to address cybersecurity issues rather than report related corrective and preventive actions to the FDA. These new options have requirements that you must know and satisfy for participation. This session will discuss these requirements.

Session Highlights

  • Statutory changes in what the FDA regulates as software
  • The use of voluntary standards for pre-market and post-market operation
  • Cybersecurity assessment elements
  • Points to consider for ISAO participation

Who Should Attend

  • Regulatory affairs directors
  • Software designers/specification developers
  • Production managers
  • Quality assurance directors
  • In-house legal counsel

Ask a question at the Q&A session following the live event and get advice unique to your situation, directly from our expert speaker.

Order Below or Call 1-866-458-2965 Today

You can also order through:




About Our Speaker

Casper E. Uldriks

 Casper (Cap) Uldriks brings over 32 years of experience from the FDA.  He specializes in the FDA’s medical device program as a field investigator, served as a senior manager in the Office of Compliance and an Associate Center Director for the Center for Devices and Radiological Health. He developed enforcement actions and participated in the implementation of new statutory requirements. He...   More Info
More Events By The Speaker

Why AudioEducator?
  • Save money on travel.
  • Meet your specific training needs.
  • Keep learning after the event.
  • Save time training your whole staff.
Join Our Mailing List
Our Accreditation Partners
Facebook Twitter Linkedin Youtube RSS Feeds Google Plus